BDNF gene: functional Val66Met polymorphism in mood disorders and schizophrenia

Bibliography

• 1  Squinto SP, Stitt TN, Aldrich TH et al.: TrkB encodes a functional receptor for brain-derived neurotrophic factor and neurotrophin-3 but not nerve growth factor. Cell65,558–568 (1991).
  Google Scholar
• 2  Ashe PC, Berry MD, Bouldton AA: Schizophrenia, a neurodegenerative disorder with neurodevelopmental antecedents. Prog. Neuropsychopharmacol. Biol. Psychiatry25,691–707 (2001).
  Medline CASGoogle Scholar
• 3  Yamada K, Mizuno M, Nabeshima T: Role for brain-derived neurotrophic factor in learning and memory. Life Sci.70,735–744 (2002).▪ Important confirmation:Seminal paper on the role of BDNF in cognitive function.
  Medline CASGoogle Scholar
• 4  Maisonpierre PC, Belluscio L, Squinto S et al.: Neurotrophin-3: a neurotrophic factor related to NGF and BDNF. Science247,1446–1451 (1990).
  Medline CASGoogle Scholar
• 5  Pruunsild P, Kazantseva A, Aid T, Palm K, Timmusk T: Dissecting the human BDNF locus: Bidirectional transcription, complex splicing, and multiple promoters. Genomics90,397–406 (2007).▪ Important confirmation:The most comprehensive recent analysis of human BDNF gene.
  Medline CASGoogle Scholar
• 6  Egan MF, Kojima M, Callicott JH et al.: The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell112,257–269 (2003).▪ New finding:First demonstration of the functionality of Val66Met polymorphism on cellular and clinical level.
  Medline CASGoogle Scholar
• 7  Pezawas L, Verchinski BA, Mattay VS et al.: The brain-derived neurotrophic factor Val66Met polymorphism and variation in human cortical morphology. J. Neurosci.24,10099–10102 (2004).
  Medline CASGoogle Scholar
• 8  Gratacos M, Gonzalez JR, Mercader JM, de Cid R, Urretavizcaya M, Estivill X: Brain-derived neurotrophis factor Val66Met and psychiatric disorders: meta-analysis of case–control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol. Psychiatry61,911–922 (2007).
  Medline CASGoogle Scholar
• 9  Hashimoto K, Shimizu E, Iyo M: Critical role of brain derived neurotrophic factor in mood disorders. Brain Res. Rev.45,104–114 (2004).
  Medline CASGoogle Scholar
• 10  Angelucci F, Brene S, Mathe AA: BDNF in schizophrenia, depression and corresponding animal models. Mol. Psychiatry.10,345–352 (2005).▪ Important confirmation:Excellent review integrating experimental and clinical data on BDNF in schizophrenia and mood disorder.
  Medline CASGoogle Scholar
• 11  Post RM: Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications. J. Psychiatr. Res.41,979–990 (2007).
  MedlineGoogle Scholar
• 12  Sklar P, Gabriel SB, McInnis MG et al.: Family-based association study of 76 candidate genes in bipolar disorder: BDNF is a potential risk locus. Mol. Psychiatry.7,579–593 (2002).
  Medline CASGoogle Scholar
• 13  Neves-Pereira M, Mundo E, Muglia P, King N, Macciardi F, Kennedy JL: The brain-derived neurotropic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet.71,651–655 (2002).
  Medline CASGoogle Scholar
• 14  Green EK, Raybould R, Macgregor S et al.: Genetic variation of brain-derived neurotrophic factor (BDNF) in bipolar disorder: case–control study of over 3000 individuals from the UK. Br. J. Psychiatry188,21–25 (2006).
  MedlineGoogle Scholar
• 15  Muller DJ, deLuca V, Sicard T, King N, Strauss J, Kennedy JL: Brain-derived neurotrophic factor gene and rapid-cycling bipolar disorders: family based association study. Br. J. Psychiatry189,317–323 (2006).
  MedlineGoogle Scholar
• 16  Frey BN, Walss-Bass C, Stanley JA et al.: Brain-derived neurotrophic factor Val66Met polymorphism affect prefrontal energy metabolism in bipolar disorder. Neuroreport18,1567–1570 (2007).
  Medline CASGoogle Scholar
• 17  Rybakowski JK, Borkowska A, Czerski PM, Skibinska M, Hauser J: Polymorphism of the brain-derived neurotrophic factor gene and performance on a cognitive prefrontal test in bipolar patients. Bipolar Disord.5,468–472 (2003).▪ New finding:First demonstration of the role of the Val66Met polymorphism in the prefrontal cognitive function in bipolar patients
  Medline CASGoogle Scholar
• 18  Rybakowski JK, Borkowska A, Skibinska M, Hauser J: Illness-specific association of Val66Met BDNF polymorphism with performance on Wisconsin Card Sorting Test in bipolar mood disorder. Mol. Psychiatry11,122–124 (2006).
  Medline CASGoogle Scholar
• 19  Karege F, Perret G, Bondolfi G, Schwald M, Bertschy G, Aubry JM: Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Res.109,143–148 (2002).
  Medline CASGoogle Scholar
• 20  Schumacher J, Jamra RA, Becker T et al.: Evidence for a relationship between genetic variants at the brain-derived neurotrophic factor (BDNF) locus and major depression. Biol. Psychiatry58,307–314 (2005).
  Medline CASGoogle Scholar
• 21  Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM: The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiol. Aging27,1834–1847 (2006).
  Medline CASGoogle Scholar
• 22  Oswald P, Del-Favero J, Massat I et al.: No implication of brain-derived neurotrophic factor (BDNF) gene in unipolar affective disorder: evidence from Belgian first and replication patient-control studies. Eur. Neuropsychopharmacol.15,491–495 (2005).
  Medline CASGoogle Scholar
• 23  Pezawas L, Meyer-Linderberg A, Goldman AL et al.: Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression. Mol. Psychiatry.13,709–716 (2008).▪ Important confirmation:Excellent review on the epistatic interaction between polymorphisms of BDNF and serotonin transporter genes.
  Medline CASGoogle Scholar
• 24  Fukumoto T, Morinobu S, Okamoto Y et al.: Chronic lithium treatment increases the expression of brain-derived neurotrophic factor in the rat brain. Psychopharmacology (Berl).158,100–106 (2001).▪ New finding:First experimental demonstration of stimulating effect of lithium on BDNF system.
  Medline CASGoogle Scholar
• 25  Rybakowski JK, Suwalska A, Skibinska M et al.: Prophylactic lithium response and polymorphism of the brain-derived neurotrophic factor gene. Pharmacopsychiatry38,166–170 (2005).▪ New finding:First demonstration of the association between Val66Met polymorphism and response to lithium prophylaxis.
  Medline CASGoogle Scholar
• 26  Rybakowski JK, Suwalska A, Skibinska M, Dmmitrzk-Weglarz M, Leszczynska-Rodziewicz A, Hauser J: Response to lithium prophylaxis: interaction between serotonin transporter and BDNF genes. Am. J. Med. Genet.144B,820–823 (2007).
  Medline CASGoogle Scholar
• 27  Matsui T, Hashimoto R, Kusumi I et al.: Lithium response and Val66Met polymorphism of the brain-derived neurotrophic factor gene in Japanese patients with bipolar disorder. Psychiatr. Genet.16,49–50 (2006).
  MedlineGoogle Scholar
• 28  Siuciak JA, Lewis DR, Wiegand SJ, Lindsay RM: Antidepressant-like effects of brain-derived neurotrophic factor (BDNF). Pharmacol. Biochem. Behav.56,131–137 (1997).▪ New finding:First demonstration of the antidepressant effect of BDNF.
  Medline CASGoogle Scholar
• 29  Nibuya M, Morinobu S, Duman RS: Regulation of BDNF and TrkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatment. J. Neurosci.15,7539–7547 (1995).
  Medline CASGoogle Scholar
• 30  Rogoz Z, Skuza G, Legutko B: Repeated treatment with mitrazepine induces brain-derived neurotrophic factor gene expression in rats. J. Physiol. Pharmacol.56,661–671 (2005).
  Medline CASGoogle Scholar
• 31  Shimizu E, Hashimoto K, Okamura N et al.: Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients without or with antidepressants. Biol. Psychiatry54,70–75 (2003).
  Medline CASGoogle Scholar
• 32  Chen B, Dowlatshahi GM, MacQueen GM, Wang JF, Young LT: Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biol. Psychiatry50,260–265 (2001).
  Medline CASGoogle Scholar
• 33  Matrisciano F, Bonacorso S, Ricciardi A et al.: Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. J. Psychiatr. Res. (2008) (Epub ahead of print).
  MedlineGoogle Scholar
• 34  Tsai SJ, Cheng CY, Yu YW, Chen TJ, Hong CJ: Association study of a brain-derived neurotrophic factor genetic polymorphism and major depressive disorders, symptomatology, and antidepressant response. Am. J. Med. Genet. B Neuropsychiatr. Genet.123,19–22 (2003).
  Google Scholar
• 35  Yoshida K, Higuchi H, Kamata M et al.: The G196A polymorphism of the brain-derived neurotrophic factor gene and the antidepressant effect of milnacipram and fluvoxamine. J. Psychopharmacol.21,650–656 (2007).
  Medline CASGoogle Scholar
• 36  Choi MJ, Kang RH, Lim SW, Oh KS, Lee MS: Brain-derived neurotrophic factor gene polymorphism (Val66Met) and citalopram response in major depressive disorder. Brain Res.1118,176–182 (2006).
  Medline CASGoogle Scholar
• 37  Zai G, Mundo E, Strauss J, Wong GWH, Kennedy JL: Brain-derived neurotrophic factor (BDNF) gene not associated with antidepressant-induced mania. Bipolar Disord.9,521–525 (2007).
  Medline CASGoogle Scholar
• 38  Durany N, Michel T, Zochling R et al.: Brain-derived neurotrophic factor and neurotrophin-3 in schizophrenic psychoses. Schizophr. Res.52,79–86 (2001).
  Medline CASGoogle Scholar
• 39  Neves-Pereira M, Cheung JK, Pasdar A et al.: BDNF gene is a risk factor for schizophrenia in a Scottish population. Mol. Psychiatry10,208–212 (2005).
  Medline CASGoogle Scholar
• 40  Rosa A, Cuesta MJ, Fatjo-Vilas M, Peralta V, Zarzuela A, Fananas L: The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with risk for psychosis: evidence from a family-based association study. Am. J. Med. Genet. B Neuropsychiatr. Genet.141,135–138 (2006).
  Google Scholar
• 41  Numata S, Ueno S, Iga J et al.: Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms. Neurosci. Lett.401,1–5 (2006).
  Medline CASGoogle Scholar
• 42  Szeszko PR, Lipsky R, Mentschel C et al.: Brain-derived neurotrophic factor Val66Met polymorphism and volume of the hippocampal formation. Mol. Psychiatry.10,631–636 (2005).
  Medline CASGoogle Scholar
• 43  Hashimoto R, Moriguchi Y, Yamashita F et al.: Dose-dependent effect of the Val66Met polymorphism of the brain-derived neurptrophic factor gene on memory-related hippocampal activity. Neurosci. Res.81,360–367 (2008).
  Google Scholar
• 44  Rybakowski JK, Borkowska A, Skibinska M et al.: Prefrontal cognition in schizophrenia and bipolar illness in relation to Val66Met polymorphism of the brain-derived neurotrophic factor gene. Psychiatry Clin. Neurosci.60,70–76 (2006).
  Medline CASGoogle Scholar
• 45  Ho BC, Andreasen NC, Dawson JD, Wassink TH: Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am. J. Psychiatry164,1890–1899 (2007).▪ New finding:Demonstration of the association of the Val66Met polymorphism with the course of schizophrenia.
  MedlineGoogle Scholar
• 46  Bai O, Chlan-Fourney J, Bowen R, Keegan D, Li XM: Expression of brain derived neurotrophic factor mRNA in rat hippocampus after treatment with antipsychotic drugs. J. Neurosci. Res.71,127–131 (2003).
  Medline CASGoogle Scholar
• 47  Park SW, Lee SK, Kim JM, Yoon JS, Kim YH: Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats. Neurosci. Lett.402,25–29 (2006).▪ New finding:First demonstration of the stimulating effect of atypical antipsychotics on the BDNF system
  Medline CASGoogle Scholar
• 48  Antilla S, Illi A, Kampman O, Mattila KM, Lehtimaki T, Leinonen E: Lack of association between two polymorphism of brain-derived neurotrophic factor and response to typical neuroleptics. J. Neural Transm.112,885–890 (2005).
  MedlineGoogle Scholar
• 49  Liou YJ, Liao DL, Chen JY et al.: Association analysis of the dopamine D3 receptor gene ser9gly and brain derived neurotrophic factor gene val66met polymorphisms with antipsychotic induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients. Neuromolecular Med.5,243–251 (2004).
  Medline CASGoogle Scholar
• 50  Hong C-J, Yu YW, Lin CH, Tsai SJ: An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients. Neurosci. Lett.349,206–208 (2003).
  Medline CASGoogle Scholar